This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Teva Pharmaceutical Industries Ltd.
Drug Names(s): TP-38
Description: Cervene (TP-38) is a targeted immunotoxin for the treatment of brain tumors. Cervene consists of TGF-beta fused with a portion of a bacterial toxin protein, Pseudomonas Exotoxin (PE).
Additional information available to subscribers only: